121 related articles for article (PubMed ID: 2702581)
1. Flow cytometry DNA ploidy analysis and catecholamine secretion profiles in neuroblastoma.
Abramowsky CR; Taylor SR; Anton AH; Berk AI; Roederer M; Murphy RF
Cancer; 1989 May; 63(9):1752-6. PubMed ID: 2702581
[TBL] [Abstract][Full Text] [Related]
2. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy in neuroblastoma.
Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of DNA ploidy for neuroblastoma.
Nakazawa M
Surg Today; 1993; 23(3):215-9. PubMed ID: 8467172
[TBL] [Abstract][Full Text] [Related]
5. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
6. DNA content and proliferative activity in children with neuroblastoma.
Yalçin B; Kutluk T; Kansu E; Göğüş S; Canpinar H; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2000; 17(1):45-54. PubMed ID: 10689714
[TBL] [Abstract][Full Text] [Related]
7. DNA content heterogeneity in neuroblastoma analyzed by means of image cytometry and its potential significance.
Melegh Z; Csernák E; Tóth E; Veleczki Z; Magyarosy E; Nagy K; Szentirmay Z
Virchows Arch; 2005 May; 446(5):517-24. PubMed ID: 15827757
[TBL] [Abstract][Full Text] [Related]
8. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
[TBL] [Abstract][Full Text] [Related]
10. Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma.
Sasagawa I; Nakada T; Kubota Y; Ishigooka M; Sawamura T; Suzuki Y
Urol Int; 1995; 54(4):181-3. PubMed ID: 7610501
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine metabolism in neuroblastoma.
LaBrosse EH; Comoy E; Bohuon C; Zucker JM; Schweisguth O
J Natl Cancer Inst; 1976 Sep; 57(3):633-8. PubMed ID: 10450
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
[TBL] [Abstract][Full Text] [Related]
14. Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening.
Kusafuka T; Nagahara N; Oue T; Imura K; Nakamura T; Kobayashi Y; Komoto Y; Fukuzawa M; Okada A; Nakayama M
Cancer; 1995 Aug; 76(4):695-9. PubMed ID: 8625168
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of neuroblastoma: correlation with prognostic variables and survival of patients.
Suzuki H; Takeuchi K
Jpn J Surg; 1988 Jan; 18(1):116-8. PubMed ID: 3386067
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of nuclear DNA content and N-myc gene amplification in neuroblastoma.
Taylor SR; Locker J
Cancer; 1990 Mar; 65(6):1360-6. PubMed ID: 2306684
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
18. DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset.
Kusafuka T; Fukuzawa M; Oue T; Yoneda A; Okada A; Satani M
J Pediatr Surg; 1994 Apr; 29(4):543-7. PubMed ID: 8014812
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors].
Yoshihiro S; Yamamoto M; Shimabukuro T; Matsuyama H; Yamamoto N; Sakatoku J
Hinyokika Kiyo; 1991 Jun; 37(6):601-5. PubMed ID: 1892008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
